seed
Stage
1
Investors
About
Lead Biologics is a spinout company from Lund University that develops therapeutic antibodies against novel targets in cancer. Their research focuses on novel immune escape mechanisms in acute myeloid leukemia, and they aim to develop first-in-class checkpoint inhibitors.
Explore Lead Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.